Literature DB >> 29082111

Heterogeneity of Fibroblasts and Myofibroblasts in Pulmonary Fibrosis.

David M Habiel1, Cory M Hogaboam1.   

Abstract

PURPOSE OF REVIEW: Idiopathic Pulmonary Fibrosis (IPF) is the most common form of interstitial lung diseases of unknown eathiopathogenesis, mean survival of 3-5 years and limited therapeutics. Characterized by a loss of alveolar type II epithelial cells and aberrant activation of stromal cells, considerable effort was undertaken to characterize the origin and activation mechanisms of fibroblasts and myofibroblasts in IPF lungs. In this review, the origin and contribution of fibroblast and myofibroblasts in lung fibrosis will be summarized. RECENT
FINDINGS: Lineage tracing experiments suggested that interstitial lung fibroblasts and lipofibroblasts, pericytes and mesothelial cells differentiate into myofibroblasts. However, epithelial and bone marrow derived cells may give rise to collagen expressing fibroblasts but do not differentiate into myofibroblasts.
SUMMARY: There is great heterogeneity in fibroblasts and myofibroblasts in fibrotic lungs. Further, there is evidence for the expansion of pericyte derived myofibroblasts and loss of lipofibroblasts and lipofibroblast derived myofibroblasts in IPF.

Entities:  

Keywords:  Fibroblast progenitors; Idiopathic Pulmonary Fibrosis; Lung Fibroblasts; Lung Fibrosis; Mesenchymal progenitors; fibroblast heterogeneity

Year:  2017        PMID: 29082111      PMCID: PMC5654579          DOI: 10.1007/s40139-017-0134-x

Source DB:  PubMed          Journal:  Curr Pathobiol Rep        ISSN: 2167-485X


  90 in total

1.  Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease.

Authors:  Borna Mehrad; Marie D Burdick; David A Zisman; Michael P Keane; John A Belperio; Robert M Strieter
Journal:  Biochem Biophys Res Commun       Date:  2006-12-11       Impact factor: 3.575

2.  Toll-like receptor 4 activation attenuates profibrotic response in control lung fibroblasts but not in fibroblasts from patients with IPF.

Authors:  Simone Ebener; Sandra Barnowski; Carlos Wotzkow; Thomas M Marti; Elena Lopez-Rodriguez; Bruno Crestani; Fabian Blank; Ralph A Schmid; Thomas Geiser; Manuela Funke
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-11-04       Impact factor: 5.464

3.  Epigenetic Regulation of Caveolin-1 Gene Expression in Lung Fibroblasts.

Authors:  Yan Y Sanders; Hui Liu; Anne M Scruggs; Steven R Duncan; Steven K Huang; Victor J Thannickal
Journal:  Am J Respir Cell Mol Biol       Date:  2017-01       Impact factor: 6.914

4.  Characterization of the platelet-derived growth factor receptor-α-positive cell lineage during murine late lung development.

Authors:  Aglaia Ntokou; Friederike Klein; Daria Dontireddy; Sven Becker; Saverio Bellusci; William D Richardson; Marten Szibor; Thomas Braun; Rory E Morty; Werner Seeger; Robert Voswinckel; Katrin Ahlbrecht
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-08-28       Impact factor: 5.464

5.  Wnt4 is essential to normal mammalian lung development.

Authors:  Arianna Caprioli; Alethia Villasenor; Lyndsay A Wylie; Caitlin Braitsch; Leilani Marty-Santos; David Barry; Courtney M Karner; Stephen Fu; Stryder M Meadows; Thomas J Carroll; Ondine Cleaver
Journal:  Dev Biol       Date:  2015-08-29       Impact factor: 3.582

6.  The role of fibroblast transdifferentiation in lung epithelial cell proliferation, differentiation, and repair in vitro.

Authors:  J S Torday; E Torres; V K Rehan
Journal:  Pediatr Pathol Mol Med       Date:  2003 May-Jun

7.  Lung fibroblasts from patients with idiopathic pulmonary fibrosis exhibit genome-wide differences in DNA methylation compared to fibroblasts from nonfibrotic lung.

Authors:  Steven K Huang; Anne M Scruggs; Richard C McEachin; Eric S White; Marc Peters-Golden
Journal:  PLoS One       Date:  2014-09-12       Impact factor: 3.240

8.  PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis.

Authors:  H Boström; K Willetts; M Pekny; P Levéen; P Lindahl; H Hedstrand; M Pekna; M Hellström; S Gebre-Medhin; M Schalling; M Nilsson; S Kurland; J Törnell; J K Heath; C Betsholtz
Journal:  Cell       Date:  1996-06-14       Impact factor: 41.582

Review 9.  Fibrocytes in lung disease.

Authors:  Brigitte N Gomperts; Robert M Strieter
Journal:  J Leukoc Biol       Date:  2007-06-05       Impact factor: 4.962

10.  Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an alpha-smooth muscle actin-Cre transgenic mouse.

Authors:  Zhuang Wu; Leilei Yang; Lin Cai; Min Zhang; Xuan Cheng; Xiao Yang; Jun Xu
Journal:  Respir Res       Date:  2007-01-07
View more
  31 in total

Review 1.  Molecular determinants of mesenchymal cell activation in fibroproliferative diseases.

Authors:  Loka R Penke; Marc Peters-Golden
Journal:  Cell Mol Life Sci       Date:  2019-09-28       Impact factor: 9.261

2.  Transforming growth factor β1 alters the 3'-UTR of mRNA to promote lung fibrosis.

Authors:  Junsuk Ko; Tingting Mills; Jingjing Huang; Ning-Yuan Chen; Tinne C J Mertens; Scott D Collum; Garam Lee; Yu Xiang; Leng Han; Yang Zhou; Chun Geun Lee; Jack A Elias; Soma S K Jyothula; Keshava Rajagopal; Harry Karmouty-Quintana; Michael R Blackburn
Journal:  J Biol Chem       Date:  2019-09-05       Impact factor: 5.157

3.  Smooth Muscle α-Actin Deficiency Leads to Decreased Liver Fibrosis via Impaired Cytoskeletal Signaling in Hepatic Stellate Cells.

Authors:  Don C Rockey; Qinghong Du; Zengdun Shi
Journal:  Am J Pathol       Date:  2019-08-30       Impact factor: 4.307

Review 4.  Fibrosis: Lessons from OMICS analyses of the human lung.

Authors:  Guoying Yu; Gabriel H Ibarra; Naftali Kaminski
Journal:  Matrix Biol       Date:  2018-03-19       Impact factor: 11.583

Review 5.  Wound healing, fibroblast heterogeneity, and fibrosis.

Authors:  Heather E Talbott; Shamik Mascharak; Michelle Griffin; Derrick C Wan; Michael T Longaker
Journal:  Cell Stem Cell       Date:  2022-08-04       Impact factor: 25.269

6.  MeCP2 epigenetically regulates alpha-smooth muscle actin in human lung fibroblasts.

Authors:  Zheyi Xiang; Qingxian Zhou; Min Hu; Yan Y Sanders
Journal:  J Cell Biochem       Date:  2020-03-01       Impact factor: 4.429

7.  Brd4-p300 inhibition downregulates Nox4 and accelerates lung fibrosis resolution in aged mice.

Authors:  Yan Y Sanders; Xing Lyv; Q Jennifer Zhou; Zheyi Xiang; Denise Stanford; Sandeep Bodduluri; Steven M Rowe; Victor J Thannickal
Journal:  JCI Insight       Date:  2020-07-23

Review 8.  Resident interstitial lung fibroblasts and their role in alveolar stem cell niche development, homeostasis, injury, and regeneration.

Authors:  Mereena George Ushakumary; Matthew Riccetti; Anne-Karina T Perl
Journal:  Stem Cells Transl Med       Date:  2021-02-24       Impact factor: 6.940

9.  Antibody-mediated depletion of CCR10+EphA3+ cells ameliorates fibrosis in IPF.

Authors:  Miriam S Hohmann; David M Habiel; Milena S Espindola; Guanling Huang; Isabelle Jones; Rohan Narayanan; Ana Lucia Coelho; Justin M Oldham; Imre Noth; Shwu-Fan Ma; Adrianne Kurkciyan; Jonathan L McQualter; Gianni Carraro; Barry Stripp; Peter Chen; Dianhua Jiang; Paul W Noble; William Parks; John Woronicz; Geoffrey Yarranton; Lynne A Murray; Cory M Hogaboam
Journal:  JCI Insight       Date:  2021-06-08

Review 10.  Idiopathic pulmonary fibrosis and systemic sclerosis: pathogenic mechanisms and therapeutic interventions.

Authors:  Hamid Mattoo; Shiv Pillai
Journal:  Cell Mol Life Sci       Date:  2021-06-18       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.